These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123). Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G eNeuro; 2015; 2(6):. PubMed ID: 26693177 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic targeting of mTOR in tuberous sclerosis. Sampson JR Biochem Soc Trans; 2009 Feb; 37(Pt 1):259-64. PubMed ID: 19143643 [TBL] [Abstract][Full Text] [Related]
26. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. El-Hashemite N; Walker V; Zhang H; Kwiatkowski DJ Cancer Res; 2003 Sep; 63(17):5173-7. PubMed ID: 14500340 [TBL] [Abstract][Full Text] [Related]
36. Missense mutations to the TSC1 gene cause tuberous sclerosis complex. Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229 [TBL] [Abstract][Full Text] [Related]
37. PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex. Alves MM; Fuhler GM; Queiroz KC; Scholma J; Goorden S; Anink J; Spek CA; Hoogeveen-Westerveld M; Bruno MJ; Nellist M; Elgersma Y; Aronica E; Peppelenbosch MP Sci Rep; 2015 Sep; 5():14534. PubMed ID: 26412398 [TBL] [Abstract][Full Text] [Related]
38. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations. Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M; Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042 [TBL] [Abstract][Full Text] [Related]
39. Mammalian target of rapamycin and tuberous sclerosis complex. Wataya-Kaneda M J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878 [TBL] [Abstract][Full Text] [Related]
40. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]